Subscribe to RSS
DOI: 10.1055/a-2770-6246
Chronic Subdural Hematomas in the Era of Middle Meningeal Artery Embolization
Authors
Abstract
Chronic subdural hematoma (cSDH) is a common, age-associated condition driven largely by ground-level falls and the widespread use of antithrombotic agents. Its burden is rising with aging population, and a substantial subset of patients meet practical criteria for middle meningeal artery embolization (MMAE). Contemporary understanding frames cSDH as a vascular-inflammatory disorder with recurrent microhemorrhage from fragile neovessels, largely supplied by branches of the middle meningeal artery. Standard care has traditionally relied on surgical evacuation, yet recurrence and reintervention remain frequent in high-risk cohorts. Over the last several years, randomized trials have evaluated MMAE as an adjunct or alternative to usual care. Three trials—EMBOLISE, STEM, and MEMBRANE—demonstrated reduced treatment failure or reoperation with adjunctive MMAE. These findings, coupled with rapid real-world adoption of MMAE, support embolization as an effective strategy to lower recurrence, especially when used with indicated surgery. Remaining questions include optimal patient selection, choice of embolic agent, target depth and laterality (distal vs. proximal, unilateral vs. bilateral), anesthesia strategy, and standardized angiographic workflows that mitigate anastomotic risks. Addressing these evidence gaps, along with health-system planning for rising volumes, will refine algorithms and improve outcomes in this growing population.
Publication History
Article published online:
10 February 2026
© 2026. Thieme. All rights reserved.
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
-
References
- 1 Uno M, Toi H, Hirai S. Chronic subdural hematoma in elderly patients: is this disease benign?. Neurol Med Chir (Tokyo) 2017; 57 (08) 402-409
- 2 Yang W, Huang J. Chronic subdural hematoma: epidemiology and natural history. Neurosurg Clin N Am 2017; 28 (02) 205-210
- 3 Neifert SN, Chaman EK, Hardigan T. et al. Increases in subdural hematoma with an aging population—the future of American cerebrovascular disease. World Neurosurg 2020; 141: e166-e174
- 4 Santarius T, Kirkpatrick PJ, Ganesan D. et al. Use of drains versus no drains after burr-hole evacuation of chronic subdural haematoma: a randomised controlled trial. Lancet 2009; 374 (9695): 1067-1073
- 5 Kudo H, Kuwamura K, Izawa I, Sawa H, Tamaki N. Chronic subdural hematoma in elderly people: present status on Awaji Island and epidemiological prospect. Neurol Med Chir (Tokyo) 1992; 32 (04) 207-209
- 6 Santarius T, Lawton R, Kirkpatrick PJ, Hutchinson PJ. The management of primary chronic subdural haematoma: a questionnaire survey of practice in the United Kingdom and the Republic of Ireland. Br J Neurosurg 2008; 22 (04) 529-534
- 7 Karibe H, Kameyama M, Kawase M, Hirano T, Kawaguchi T, Tominaga T. [Epidemiology of chronic subdural hematomas] [in Japanese]. No Shinkei Geka 2011; 39 (12) 1149-1153
- 8 El Rahal A, Beck J, Ahlborn P. et al. Incidence, therapy, and outcome in the management of chronic subdural hematoma in Switzerland: a population-based multicenter cohort study. Front Neurol 2023; 14: 1206996
- 9 Gelabert-González M, Iglesias-Pais M, García-Allut A, Martínez-Rumbo R. Chronic subdural haematoma: surgical treatment and outcome in 1000 cases. Clin Neurol Neurosurg 2005; 107 (03) 223-229
- 10 Rubenstein LZ. Falls in older people: epidemiology, risk factors and strategies for prevention. Age Ageing 2006; 35 (Suppl. 02) ii37-ii41
- 11 Rai AT, Halak AA, Lakhani DA, Tarabishy AR, Siddiqui AH. Population-based estimates suggest middle meningeal artery embolization for subdural hematomas could significantly expand the scope of neurovascular therapies. J Neurointerv Surg 2025; 17 (04) 438-443
- 12 Cuevas-Trisan R. Balance problems and fall risks in the elderly. Clin Geriatr Med 2019; 35 (02) 173-183
- 13 Rai AT, Link PS, Lakhani DA. Rising tide of middle meningeal artery embolization for chronic subdural hematomas: current volumes and future growth compared with cerebral aneurysm and stroke interventions. J Neurointerv Surg 2026; 18 (02) 547-551
- 14 Ducruet AF, Grobelny BT, Zacharia BE. et al. The surgical management of chronic subdural hematoma. Neurosurg Rev 2012; 35 (02) 155-169 , discussion 169
- 15 Edlmann E, Giorgi-Coll S, Whitfield PC, Carpenter KLH, Hutchinson PJ. Pathophysiology of chronic subdural haematoma: inflammation, angiogenesis and implications for pharmacotherapy. J Neuroinflammation 2017; 14 (01) 108
- 16 Saito H, Tanaka M, Hadeishi H. Angiogenesis in the septum and inner membrane of refractory chronic subdural hematomas: consideration of findings after middle meningeal artery embolization with low-concentration n-butyl-2-cyanoacrylate. NMC Case Rep J 2019; 6 (04) 105-110
- 17 Feghali J, Yang W, Huang J. Updates in chronic subdural hematoma: epidemiology, etiology, pathogenesis, treatment, and outcome. World Neurosurg 2020; 141: 339-345
- 18 Bonasia S, Smajda S, Ciccio G, Robert T. Middle meningeal artery: anatomy and variations. AJNR Am J Neuroradiol 2020; 41 (10) 1777-1785
- 19 Chmielewski P, Skrzat J, Walocha J. Clinical importance of the middle meningeal artery. Folia Med Cracov 2013; 53 (01) 41-46
- 20 Griessenauer CJ, He L, Salem M, Chua MH, Ogilvy CS, Thomas AJ. Middle meningeal artery: gateway for effective transarterial Onyx embolization of dural arteriovenous fistulas. Clin Anat 2016; 29 (06) 718-728
- 21 Fiorella D, Arthur AS. Middle meningeal artery embolization for the management of chronic subdural hematoma. J Neurointerv Surg 2019; 11 (09) 912-915
- 22 Fiorella D, Monteith SJ, Hanel R. et al. Embolization of the middle meningeal artery for chronic subdural hematoma. N Engl J Med 2025; 392 (09) 855-864
- 23 Davies JM, Knopman J, Mokin M. et al; EMBOLISE Investigators. Adjunctive middle meningeal artery embolization for subdural hematoma. N Engl J Med 2024; 391 (20) 1890-1900
- 24 Rai AT, Kellner CP, Shoirah H. et al. Middle Meningeal Artery Embolization Treatment of Subdural Hematomas with TRUFILL n-BCA: MEMBRANE Trial Primary Results. Presented at: Society of Vascular and Interventional Neurology. San Diego; 2024
- 25 Liu J, Ni W, Zuo Q. et al; MAGIC-MT Investigators. Middle meningeal artery embolization for nonacute subdural hematoma. N Engl J Med 2024; 391 (20) 1901-1912
- 26 Jindal G, Sharafaddin-Zadeh Y, Bukhari O, Goyal M, Ospel JM. Complications of middle meningeal artery embolization for chronic subdural hematoma: a systematic literature review. Can J Neurol Sci 2025; 1-11 . Epub ahead of print
- 27 Shafi M, Badikol SR, Gerstl JVE. et al. Complications of middle meningeal artery embolization: a systematic review and meta-analysis. World Neurosurg 2025; 194: 123541
- 28 Cristaldi PMF, Rui CB, Piergallini L. et al. Facial nerve palsy after middle meningeal artery embolization for chronic subdural hematoma: a case report. Acta Neurochir (Wien) 2024; 166 (01) 312
- 29 Lambert-Cheatham NA, Pasmanter NR, Nagia L. Oculomotor and facial nerve palsies after middle meningeal artery embolization. J Neuroophthalmol 2024; 44 (03) e447-e449
- 30 Ferber A, Zhou Y, Greenwald B. Persistent facial nerve palsy after middle meningeal artery embolization for subdural hematoma: a case report. Brain Inj 2023; 37 (05) 457-460
- 31 Pilawska SA, Krzyżewski RM, Dębicka M. et al. Facial nerve palsy as a complication of middle meningeal artery embolization for chronic subdural hematoma: report of 3 cases and review of literature. World Neurosurg 2025; 199: 124128
- 32 Hayashi N, Kubo M, Tsuboi Y. et al. Impact of anomalous origin of the ophthalmic artery from the middle meningeal artery on selection of surgical approach to skull base meningioma. Surg Neurol 2007; 68 (05) 568-571 , discussion 571–572
- 33 Meguro T, Tomita Y, Tanabe T. et al. [Embolization of the feeding artery of a meningioma with dangerous vascular anastomosis between the middle meningeal artery and the ophthalmic artery] [in Japanese]. No Shinkei Geka 2013; 41 (11) 995-999

